11-01 :: December 2010 / January 2011
nanotimes
Companies Facts
Additionally, new orders received in 2010 from our Conceptronic and SDC divisions increased by 53% and 40% respectively compared to 2009.
http://www.CVDequipment.com
D
anaher Corporation (NYSE:DHR) has entered into a definitive merger agreement with Beck-
man Coulter, Inc. (NYSE: BEC) pursuant to which Danaher will acquire Beckman Coulter by making a cash tender offer to acquire all of the outstanding shares of common stock of Beckman Coulter at a purchase price of $83.50 per share, for a total enter- prise value of approximately $6.8 billion, including debt assumed and net of cash acquired.
http://www.danaher.com
D
omainex Ltd, the leading UK-based drug discovery CRO, has won the 2010 Genesis Life
Science Innovation and Enterprise Programme Of The Year Award. This Award was made in recognition of Domainex’s proactive work on promoting academic- industry collaborations, and was adjudicated by leading representatives of the biotechnology and pharmaceutical industries. Domainex has developed a number of platform technologies specifically aimed at enabling biotech or pharma companies who have exciting new drug targets. Its Combinatorial Do- main Hunting (CDH) technology will deliver protein constructs that are soluble, stable, and produced in high-yield – thereby opening up the path to high throughput screening, structural biology, or antibody production.
http://www.domainex.co.uk
D
yeTec Solar Inc., a joint venture involving Dyesol Inc. (DYE), a wholly owned subsidiary of Dyesol Ltd. will receive a US$1 million Ohio Third
Frontier Commission grant to develop technology for mass manufacture of glass based BIPV (Building Integrated Photovoltaic’s), BAPV (Building Applied Photovoltaic’s) and AIPV (Automotive Integrated Photovoltaic’s) products.
DyeTec’s technology is designed to utilise optimised Transparent Conductive Oxide (TCO) glass and Dye Solar Cell (DSC) materials manufactured by the JV partners, and enables downstream suppliers in the glass market to mass produce high performing DSC – TCO glass based products for use in BIPV, BAPV and AIPV environments. Initial DyeTec efforts will result in the development of prototype DSC based BIPV glass panels and related equipment sets, laying the foundation for future high volume manufacturing capability.
“DyeTec is fortunate to be able to leverage Toledo’s rich history in glass processing and solar technology as well as a talented workforce. And with strong go- vernment and shareholder support, Ohio represents an ideal environment for DyeTec Solar to grow its R&D and manufacturing centres” states Marc Tho- mas, CEO of Dyesol Inc., and President of DyeTec Solar. BIPV and BAPV represent the single largest markets for both DSC and TEC technology. With commercial and residential building consuming over 70% of all the energy used in the US today, and of that 70%, over 25% is in the form of electricity. This 25% equates to a demand of approximately 820 GW in the built environment, and by contrast, in 2008, total PV deployment in the US was .6 GW. DyeTec’s glass based DSC technology is ideally suited to cap- ture and convert the light on all sides of a building into electricity for immediate use within the building, and/or supply electricity directly into the grid.
21
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95